AAAAAA

   
Results: 1-8 |
Results: 8
OLANZAPINE - A NEW ANTIPSYCHOTIC AGENT WITH EFFICACY IN THE MANAGEMENT OF SCHIZOPHRENIA
Authors: KANDO JC SHEPSKI JC SATTERLEE W PATEL JK REAMS SG GREEN AI
Citation: Jc. Kando et al., OLANZAPINE - A NEW ANTIPSYCHOTIC AGENT WITH EFFICACY IN THE MANAGEMENT OF SCHIZOPHRENIA, The Annals of pharmacotherapy, 31(11), 1997, pp. 1325-1334
OLANZAPINE VERSUS PLACEBO - RESULTS OF A DOUBLE-BLIND, FIXED-DOSE OLANZAPINE TRIAL
Authors: BEASLEY CM SANGER T SATTERLEE W TOLLEFSON G TRAN P HAMILTON S GREEN A DOTT S PFISTER G ROXAS L SMALL J THOMAS M AMES D SCHOOLER N BAKER R LEVINE R FABRE L FRIEDEL R SAFFERMAN A LIEBERMAN J STAHL S
Citation: Cm. Beasley et al., OLANZAPINE VERSUS PLACEBO - RESULTS OF A DOUBLE-BLIND, FIXED-DOSE OLANZAPINE TRIAL, Psychopharmacology, 124(1-2), 1996, pp. 159-167
OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL
Authors: BEASLEY CM TOLLEFSON G TRAN P SATTERLEE W SANGER T HAMILTON S FABRE L SMALL J ERESHEFSKY L TRUE J NEMEROFF C RISCH SC PERRY PJ POTKIN SG BORISON RL JAMES S MELTZER HY IQBAL N FANN WE GEWIRTZ GR LANDBLOOM R ROYBYRNE PP TUASON VB CARMAN JS STOKES PE WILLIAMS R ANCILL RJ MACEWAN GW GUJAVARTY KS JONES B LOHR JB
Citation: Cm. Beasley et al., OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL, Neuropsychopharmacology, 14(2), 1996, pp. 111-123
EFFECTIVENESS OF OLANZAPINE IN LONG-TERM CONTINUATION TREATMENT
Authors: SATTERLEE W DELLVA MA BEASLEY C TRAN P TOLLEFSON O
Citation: W. Satterlee et al., EFFECTIVENESS OF OLANZAPINE IN LONG-TERM CONTINUATION TREATMENT, Psychopharmacology bulletin, 32(3), 1996, pp. 509-509
ADDITIONAL CLINICAL-EXPERIENCE WITH OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC
Authors: SATTERLEE W BEASLEY C SANGER T TOLLEFSON G
Citation: W. Satterlee et al., ADDITIONAL CLINICAL-EXPERIENCE WITH OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC, Schizophrenia research, 15(1-2), 1995, pp. 163-163
OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC
Authors: SATTERLEE W BEASLEY C SANGER T TRAN P TOLLEFSON G
Citation: W. Satterlee et al., OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC, Schizophrenia research, 15(1-2), 1995, pp. 163-164
SYNTHESIS OF[C-11]DAPOXETINE-CENTER-DOT-HCL, A SEROTONIN REUPTAKE INHIBITOR - BIODISTRIBUTION IN RAT AND PRELIMINARY PET IMAGING IN THE MONKEY
Authors: LIVNI E SATTERLEE W ROBEY RL ALT CA VANMETER EE BABICH JW WHEELER WJ OBANNON DD THRALL JH FISCHMAN AJ
Citation: E. Livni et al., SYNTHESIS OF[C-11]DAPOXETINE-CENTER-DOT-HCL, A SEROTONIN REUPTAKE INHIBITOR - BIODISTRIBUTION IN RAT AND PRELIMINARY PET IMAGING IN THE MONKEY, Nuclear medicine and biology, 21(4), 1994, pp. 669-675
OLANZAPINE - A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT - PHASE-II CLINICAL FINDINGS
Authors: HARRISON DA SATTERLEE W TRAN P BEASLEY CM TOLLEFSON GD
Citation: Da. Harrison et al., OLANZAPINE - A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT - PHASE-II CLINICAL FINDINGS, Schizophrenia research, 11(2), 1994, pp. 107-107
Risultati: 1-8 |